Therefore, exosomal miRNA-146a in MSCs might alleviate experimental colitis by targeting the TRAF6 and IRAK1 genes [35], preventing NF-κB activation along with the subsequent production of TNF-α and IL-6 [35]. Here, NFKB1 is linked to colitis.